Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
TK008: Randomized phase III trial of haploidentical HCTwith or without an add back strategy of HSV-Tk donor lymphocytes in patients with high risk acute leukemia

Proposed period of release:
01/11/2012 to 30/11/2015

Name of the Institute(s) or Company(ies)
MolMed SpA, Via Olgettina 558 20132
Milano (Italy);

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Murine cell with MCH=H-2q haplotype. The cells are obtained from ATCC (ATCC cat # CRL

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
mousemusmusculusNIH Swiss

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known